Date | Time | Source | Headline | Symbol | Company |
09/10/2024 | 3:00PM | iHub Newswire | FeaturedElement79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates | | |
06/09/2010 | 11:56AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
06/09/2010 | 8:00AM | Business Wire | Forest Laboratories, Inc. Announces Accelerated Share Repurchase | NYSE:FRX | Forest Road Acquisition Corp |
06/08/2010 | 9:00AM | Dow Jones News | Forest Labs, TransTech In Licensing Deal For Up To $1.11 Billion | NYSE:FRX | Forest Road Acquisition Corp |
06/08/2010 | 8:00AM | Business Wire | Forest Laboratories & TransTech Pharma Enter Into License Agreement for the Development & Commercialization of Glucokinase Ac... | NYSE:FRX | Forest Road Acquisition Corp |
06/08/2010 | 8:00AM | Business Wire | Forest Laboratories & TransTech Pharma Enter Into License Agreement for the Development & Commercialization of Glucokinase Ac... | NYSE:FRX | Forest Road Acquisition Corp |
05/19/2010 | 9:31AM | PR Newswire (US) | Critical Alerts for Google, Pfizer, Newmont Mining, Forest Laboratories, and Accenture Released by Seven Summits Research | NYSE:FRX | Forest Road Acquisition Corp |
05/18/2010 | 8:41AM | Business Wire | Forest Laboratories, Inc. Announces New Share Repurchase Program | NYSE:FRX | Forest Road Acquisition Corp |
05/17/2010 | 6:45PM | Business Wire | Forest Laboratories and Nycomed Receive Complete Response Letter for Roflumilast | NYSE:FRX | Forest Road Acquisition Corp |
05/11/2010 | 2:30AM | Business Wire | Forest & Almirall to Present Data from Studies of Aclidinium Bromide in Chronic Obstructive Pulmonary Disease (COPD) & LAS100... | NYSE:FRX | Forest Road Acquisition Corp |
05/10/2010 | 2:00AM | Business Wire | Forest and Nycomed to Present Results from Six Roflumilast Posters | NYSE:FRX | Forest Road Acquisition Corp |
05/06/2010 | 10:15AM | Dow Jones News | Sun Pharmaceutical Gets U.S. OK For Generic Namenda Tablets | NYSE:FRX | Forest Road Acquisition Corp |
05/03/2010 | 6:13PM | Business Wire | New Data Demonstrate Efficacy and Tolerabilty of Bystolic® (Nebivolol) Tablets among Hispanics with Hypertension | NYSE:FRX | Forest Road Acquisition Corp |
05/03/2010 | 6:05PM | Business Wire | Ironwood and Forest Present Positive Linaclotide Results from Two Pivotal Phase 3 Trials in Patients with Chronic Constipation | NYSE:FRX | Forest Road Acquisition Corp |
04/29/2010 | 6:52AM | Dow Jones News | Orchid Chemicals Settles Alzheimer's Drug Litigation With Forest Labs | NYSE:FRX | Forest Road Acquisition Corp |
04/26/2010 | 6:48PM | Business Wire | Ironwood and Forest to Present Linaclotide Phase 3 Chronic Constipation Data | NYSE:FRX | Forest Road Acquisition Corp |
04/23/2010 | 8:53AM | Dow Jones News | Nycomed, Forest Lung Drug Daxas Gets EU Backing | NYSE:FRX | Forest Road Acquisition Corp |
04/20/2010 | 3:19PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
04/20/2010 | 10:03AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
04/20/2010 | 9:22AM | Dow Jones News | Forest Labs 4Q Profit Drops 76% On Charges; Revenue Up | NYSE:FRX | Forest Road Acquisition Corp |
04/20/2010 | 8:00AM | Business Wire | Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2010 Earnings Per Share of $0.07, Including a One-Time Charge To... | NYSE:FRX | Forest Road Acquisition Corp |
04/16/2010 | 7:30AM | Marketwired | (OTC: KKUR) ChromoCure to Acquire $25 Million in IP and Technology for Cancer Detection | NYSE:FRX | Forest Road Acquisition Corp |
04/08/2010 | 1:37PM | Dow Jones News | UPDATE: Forest Labs Down 12% After Negative FDA Panel Vote | NYSE:FRX | Forest Road Acquisition Corp |
04/08/2010 | 12:52PM | Dow Jones News | Forest Labs Declines 12% After Negative FDA Panel Vote | NYSE:FRX | Forest Road Acquisition Corp |
04/07/2010 | 5:19PM | Dow Jones News | UPDATE:FDA Panel Votes Against Approval Of Forest Lung Drug Daxas | NYSE:FRX | Forest Road Acquisition Corp |
04/07/2010 | 4:57PM | Dow Jones News | FDA Panel Votes Against Approval Of Forest Lung Drug Daxas | NYSE:FRX | Forest Road Acquisition Corp |
04/07/2010 | 4:22PM | Dow Jones News | FDA Panel: Forest Lung Drug Daxas Appears Effective | NYSE:FRX | Forest Road Acquisition Corp |
04/05/2010 | 4:43PM | Dow Jones News | UPDATE:FDA: Effectiveness Of Forest's Lung Drug 'Quite Modest' | NYSE:FRX | Forest Road Acquisition Corp |
04/05/2010 | 10:10AM | Dow Jones News | FDA: Effectiveness Of Forest Lung Drug Daxas `Quite Modest' | NYSE:FRX | Forest Road Acquisition Corp |
04/01/2010 | 11:18AM | Business Wire | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2010 Fourth Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |